COVID-19 Records

Daszak CBP Package — page 4

of 23 pages

← p.3 p.5 → · this page in the original PDF · package

¢ DASZAK was asked publicly by NIH to retrieve the original type-specimen used by WIV for genetic analysis, and return it to the United States. He was also asked to explain several aspects of their collaboration, including related to cell phone data. Link ¢ DASZAK and EcoHealth has been awarded a number of contracts and grants from the U.S. federal government. These include contracts with the DHS Chemical and Biological Threat Division. Many items that EcoHealth studies are likely to be subject to serious non-disclosure agreements with the U.S. government and/or be export controlled. ¢ Much of the funding DASZAK receives is put towards gain of function research. This research involves experimentation that aims or is expected to increase the tran: lity and/or virulence of pathogens. The ultimate objective of such research is to better inform public health and preparedness efforts and/or development of medical countermeasures. Link e In 2013, DASZAK was a coauthor of publication "Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor" with Zhengli SHI and Ralph BARIC. This paper is of significance due to the first reporting of a SL-CoV-WIV1 (SARS-like coronavirus WIV1) binding to human cells and infecting them. Link ¢ A follow up article published in Nature magazine on 12/12/2015 titled "Engineered bat virus stirs debate over risky research, Lab-made coronavirus related to SARS can infect human cells" debates "whether engineering lab variants of viruses with possible pandemic potential is worth the risks." Link NTC Requests e TTRT exam to include review of media (search level determined by POE). e Why was DASZAK chosen to be on the WHO investigative team? e Where in China did DASZAK go? e Where did DASZAK stay while in China? e Who was the POC? Did the team visit WIV? If so, what areas did they inspect? Who did the team meet with? e Did the team visit the Chinese Center for Disease Control and Prevention? If so, what areas did they inspect? Who did the team meet with? e Did the team meet with any other officials from the Chinese government? e Did DASZAK collect any biological samples during the trip? e Is DASZAK traveling with any biological samples? e Did he mail any samples back to the US? e Did he take any materials with him to China? e Has DASZAK maintained contact with anyone at the WIV? If so, whom and how often would he communicate? What do they communicate about? e What was the purpose of DASZAK's travel from 01/04/2021-01/07/2021? Respectfully, = a rity Specialist ational Targeting Center (NTC) Tactical Targeting

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/daszak_cbp/4

Records on this page

RecordDateTypePages
daszak_cbp:exh:00004 attachment 4